Massive companies overseeing prescriptions for millions in the U.S. must soon disclose profits from drugmakers. This is due to a new rule announced by the Trump administration on Thursday.
The Labor Department regulation mandates that pharmacy benefit managers reveal payments for pharmaceuticals and amounts received from drug companies. These managers negotiate drug benefits for employees and those on healthcare plans.
President Trump aims to lower drug costs and boost transparency in healthcare. Labor Secretary Keith Sonderling noted the rule ensures price transparency and competition cannot be avoided in the industry.
This regulation helps employers negotiate better deals and reduce drug costs for over 72 million self-insured Americans.
“The rule responds to criticisms that pharmacy benefit managers exploit a lack of transparency to push more expensive drugs,” said Keith Sonderling.
Despite this, large pharmacy benefit managers like Express Scripts, CVS’s Caremark, and UnitedHealth Group’s Optum Rx, which handle about 80 percent of prescription claims, have pushed back against the rule.
The rule takes effect in healthcare plans starting in July.
